A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1500 participants.
Also called NCT06168942
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,500 participants
- Sponsor
- Jaguar LAA, Inc.
- Registry
-
NCT06168942
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Suspended
Technical summary
Registry record NCT06168942. Randomized; no masking; primary purpose treatment. Start 2024-02-19 (actual); primary completion 2028-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
- Condition
- Non-valvular Atrial Fibrillation
- Condition
- Stroke
- Condition
- Systemic Embolism
- Intervention (Device)
- Experimental: Laminar Left Atrial Appendage Closure System
- Intervention (Device)
- Active Comparator: WATCHMAN / Amulet
- Lead sponsor
- Jaguar LAA, Inc.
Record details
- Record id
cardio:ct-nct06168942- Content hash
3bf54641a17d18ff69e4993329715e63c374c7e52e01dc3bc44db35b8dd15288